Global e-Prescribing Market By Offering (Solutions (Integrated, Standalone) Services) By Deployment (Cloud based, On-premise) By Platform (App based, Web based) By End Users (Patients, Hospital and Clinics, Pharmacies, Telemedicine and HER companies, Others) By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2023 – 2031
Industry Trends
E-prescribing, or electronic prescribing, happens to be the process of using digital technology to create and transmit prescriptions for medications from a healthcare provider to a pharmacy. Courtesy of changing times, especially environmental issues, instead of penning a paper prescription, a doctor or a medical expert enters the prescription information into a computer, which is ultimately transmitted securely to the pharmacy. E-prescribing possesses multiple benefits as compared to traditional paper prescriptions. These benefits vary from improved accuracy, increased efficiency, enhanced safety and convenience. While e-prescribing eliminates errors caused by illegible handwriting or transcription errors, it also streamlines the prescription process, cutting down the time and effort required by healthcare providers and pharmacists. On the other hand, e-prescribing systems are capable of automatically checking for drug interactions and other potential issues, bringing down the risk of medication errors. E-prescribing also helps the patients to skip the step of dropping off a physical prescription at the pharmacy, as the prescription can be transmitted directly to the pharmacy of their choice. Owing to numerous factors, the global e-prescribing market has been taking steps on the path of progress.
As per a recent report by the Office of the National Coordinator for Health Information Technology (ONC), as of 2020, nearly 94% of all pharmacies in the country of the United States were able to receive electronic prescriptions. Along with this, the report also found that 81% of office-based physicians and 96% of non-federal acute care hospitals were using certified electronic health record (EHR) technology to prescribe medications. In terms of revenue, global e-prescribing market was valued at US$ 2.89 Bn in 2022, growing at a CAGR of 25.4% over the forecast period (2023 – 2031). The study analyses the market in terms of revenue across all the major continents/regions, which have been bifurcated into countries.
Deployment Outlook
Based on the deployment outlook, the global e-prescribing market has been segmented into cloud-based and on-premise. The cloud-based segment accounts for majority of revenue generated by this market. This is because cloud-based software has many benefits for businesses and organizations, like ease of accessibility, scalability and it is cost-effective. This type can be accessed from anywhere with an internet connection, which means that employees can work remotely and collaborate with others in real-time, without the need for physical office space or servers. Cloud-based software can be easily scaled up or down for the purpose of accommodating changes in demand, making it an ideal solution for businesses with fluctuating needs. It also cuts down various costs associated with hardware or other installation charges. Surescripts, one of the largest e-prescribing networks in the US, has its e-prescribing platform hosted in the cloud. The platform supports electronic prescribing for both controlled and non-controlled substances and integrates with electronic health record (EHR) systems to enable seamless prescribing workflows.
Platform Outlook
The platform outlook segment of the global e-prescribing market has been bifurcated into app based and web based. The app based platform is seeing surge in the popularity as apps grant a convenient way to access data and services from anywhere at any time. With just a couple of taps on a mobile device, users can access the information they need without the need for a computer or browser. This is the reason; this segment makes most of the money for the market.
Region Outlook
Based on region, the continent of North America accounted for largest share of revenue generated by the global e-prescribing market. Higher awareness among people and medical or health practitioners, and massive technological advancements has been driving the growth of the market in this territory. Additionally, several regulatory mandates have been implemented in the U.S. and Canada to encourage the adoption of e-prescribing. For example, in the US, the Medicare Improvements for Patients and Providers Act (MIPPA) requires electronic prescribing for certain medications covered by Medicare Part D, while in Canada, the Canadian Council on Health Services Accreditation (CCHSA) requires healthcare organizations to have an e-prescribing system in place.
Competitive Landscape
The report provides both, qualitative and quantitative research of global e-prescribing market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the global e-prescribing market are
- Advanced Data Systems
- AdvancedMD, Inc.
- Bizmatics, Inc.
- DrFirst
- eazyScripts
- Henry Schein Medical Systems, Inc
- Innovation Compounding
- Kareo, Inc.
- MDToolbox
- MedicalMine Inc.
- Practice Fusion, Inc.
- PRN Software, LLC
- RXNT
- Streamline Healthcare Solutions
- Surescripts
- Veradigm LLC (Allscripts)
- Wolters Kluwer N.V.
- Other Market Participants
Global e-Prescribing Market:
By Offering
- Solutions
- Integrated
- Standalone
- Services
By Deployment
- Cloud based
- On-premise
By Platform
- App based
- Web based
By End Users
- Patients
- Hospital and Clinics
- Pharmacies
- Telemedicine and HER companies
- Others
By Region
- North America (U.S., Canada, Mexico, Rest of North America)
- Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe
- Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific
- Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
- Latin America (Brazil, Argentina, Rest of Latin America)
Table of Contents
1. Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2021
1.2.2. Base
Year: 2022
1.2.3. Forecast
Years: 2023 - 2031
2. Key Target Audiences
3. Research Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of E-Priscribing Market
6. Market Synopsis:
E-Priscribing Market
7. E-Priscribing Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.2.4. Challenges
7.3. Trends in
E-Priscribing Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: E-Priscribing Market
7.6. Impact of
Covid-19 on E-Priscribing Market
7.7. PESTEL
Analysis
8. Global E-Priscribing Market Analysis and Forecasts, 2023 -
2031
8.1. Overview
8.1.1. Global
E-Priscribing Market Revenue (US$ Mn)
8.2. Global
E-Priscribing Market Revenue (US$ Mn) and Forecasts, By Offering
8.2.1. Solutions (Definition, Market Estimation and
Penetration, 2015 - 2022, Market Estimation (2015 - 2022), Market Forecast (2023
- 2031), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North
America, Europe, Asia Pacific, Middle East and Africa, Latin America) and
Information on Integrated , Standalone )
8.2.1.1. Integrated
8.2.1.2. Standalone
8.2.2. Services
8.2.2.1. Definition
8.2.2.2. Market Estimation and Penetration, 2015 - 2022
8.2.2.3. Market Forecast, 2023 - 2031
8.2.2.4. Compound Annual Growth Rate (CAGR)
8.2.2.5. Regional Bifurcation
8.2.2.5.1. North America
8.2.2.5.1.1. Market
Estimation, 2015 - 2022
8.2.2.5.1.2. Market
Forecast, 2023 - 2031
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2015 - 2022
8.2.2.5.2.2. Market
Forecast, 2023 - 2031
8.2.2.5.3. Asia Pacific
8.2.2.5.3.1. Market
Estimation, 2015 - 2022
8.2.2.5.3.2. Market
Forecast, 2023 - 2031
8.2.2.5.4. Middle East and Africa
8.2.2.5.4.1. Market
Estimation, 2015 - 2022
8.2.2.5.4.2. Market
Forecast, 2023 - 2031
8.2.2.5.5. Latin America
8.2.2.5.5.1. Market
Estimation, 2015 - 2022
8.2.2.5.5.2. Market
Forecast, 2023 - 2031
8.3. Key
Segment for Channeling Investments
8.3.1. By
Offering
9. Global E-Priscribing Market Analysis and Forecasts, 2023 -
2031
9.1. Overview
9.2. Global
E-Priscribing Market Revenue (US$ Mn) and Forecasts, By Deployment
9.2.1. Cloud
based
9.2.1.1. Definition
9.2.1.2. Market Estimation and Penetration, 2015 - 2022
9.2.1.3. Market Forecast, 2023 - 2031
9.2.1.4. Compound Annual Growth Rate (CAGR)
9.2.1.5. Regional Bifurcation
9.2.1.5.1. North America
9.2.1.5.1.1. Market
Estimation, 2015 - 2022
9.2.1.5.1.2. Market
Forecast, 2023 - 2031
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 - 2022
9.2.1.5.2.2. Market
Forecast, 2023 - 2031
9.2.1.5.3. Asia Pacific
9.2.1.5.3.1. Market
Estimation, 2015 - 2022
9.2.1.5.3.2. Market
Forecast, 2023 - 2031
9.2.1.5.4. Middle East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 - 2022
9.2.1.5.4.2. Market
Forecast, 2023 - 2031
9.2.1.5.5. Latin America
9.2.1.5.5.1. Market
Estimation, 2015 - 2022
9.2.1.5.5.2. Market
Forecast, 2023 - 2031
9.2.2. On
–premise
9.2.2.1. Definition
9.2.2.2. Market Estimation and Penetration, 2015 - 2022
9.2.2.3. Market Forecast, 2023 - 2031
9.2.2.4. Compound Annual Growth Rate (CAGR)
9.2.2.5. Regional Bifurcation
9.2.2.5.1. North America
9.2.2.5.1.1. Market
Estimation, 2015 - 2022
9.2.2.5.1.2. Market
Forecast, 2023 - 2031
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 - 2022
9.2.2.5.2.2. Market
Forecast, 2023 - 2031
9.2.2.5.3. Asia Pacific
9.2.2.5.3.1. Market
Estimation, 2015 - 2022
9.2.2.5.3.2. Market
Forecast, 2023 - 2031
9.2.2.5.4. Middle East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 - 2022
9.2.2.5.4.2. Market
Forecast, 2023 - 2031
9.2.2.5.5. Latin America
9.2.2.5.5.1. Market
Estimation, 2015 - 2022
9.2.2.5.5.2. Market
Forecast, 2023 - 2031
9.3. Key
Segment for Channeling Investments
9.3.1. By
Deployment
10. Global E-Priscribing Market Analysis and Forecasts, 2023 -
2031
10.1. Overview
10.2. Global
E-Priscribing Market Revenue (US$ Mn) and Forecasts, By Platform
10.2.1. App
based
10.2.1.1. Definition
10.2.1.2. Market Estimation and Penetration, 2015 - 2022
10.2.1.3. Market Forecast, 2023 - 2031
10.2.1.4. Compound Annual Growth Rate (CAGR)
10.2.1.5. Regional Bifurcation
10.2.1.5.1. North America
10.2.1.5.1.1. Market
Estimation, 2015 - 2022
10.2.1.5.1.2. Market
Forecast, 2023 - 2031
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2015 - 2022
10.2.1.5.2.2. Market
Forecast, 2023 - 2031
10.2.1.5.3. Asia Pacific
10.2.1.5.3.1. Market
Estimation, 2015 - 2022
10.2.1.5.3.2. Market
Forecast, 2023 - 2031
10.2.1.5.4. Middle East and Africa
10.2.1.5.4.1. Market
Estimation, 2015 - 2022
10.2.1.5.4.2. Market
Forecast, 2023 - 2031
10.2.1.5.5. Latin America
10.2.1.5.5.1. Market
Estimation, 2015 - 2022
10.2.1.5.5.2. Market
Forecast, 2023 - 2031
10.2.2. Web
based
10.2.2.1. Definition
10.2.2.2. Market Estimation and Penetration, 2015 - 2022
10.2.2.3. Market Forecast, 2023 - 2031
10.2.2.4. Compound Annual Growth Rate (CAGR)
10.2.2.5. Regional Bifurcation
10.2.2.5.1. North America
10.2.2.5.1.1. Market
Estimation, 2015 - 2022
10.2.2.5.1.2. Market
Forecast, 2023 - 2031
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2015 - 2022
10.2.2.5.2.2. Market
Forecast, 2023 - 2031
10.2.2.5.3. Asia Pacific
10.2.2.5.3.1. Market
Estimation, 2015 - 2022
10.2.2.5.3.2. Market
Forecast, 2023 - 2031
10.2.2.5.4. Middle East and Africa
10.2.2.5.4.1. Market
Estimation, 2015 - 2022
10.2.2.5.4.2. Market
Forecast, 2023 - 2031
10.2.2.5.5. Latin America
10.2.2.5.5.1. Market
Estimation, 2015 - 2022
10.2.2.5.5.2. Market
Forecast, 2023 - 2031
10.3. Key
Segment for Channeling Investments
10.3.1. By
Platform
11. Global E-Priscribing Market Analysis and Forecasts, 2023 -
2031
11.1. Overview
11.2. Global
E-Priscribing Market Revenue (US$ Mn) and Forecasts, By End Users
11.2.1. Patients
11.2.1.1. Definition
11.2.1.2. Market Estimation and Penetration, 2015 - 2022
11.2.1.3. Market Forecast, 2023 - 2031
11.2.1.4. Compound Annual Growth Rate (CAGR)
11.2.1.5. Regional Bifurcation
11.2.1.5.1. North America
11.2.1.5.1.1. Market
Estimation, 2015 - 2022
11.2.1.5.1.2. Market
Forecast, 2023 - 2031
11.2.1.5.2. Europe
11.2.1.5.2.1. Market
Estimation, 2015 - 2022
11.2.1.5.2.2. Market
Forecast, 2023 - 2031
11.2.1.5.3. Asia Pacific
11.2.1.5.3.1. Market
Estimation, 2015 - 2022
11.2.1.5.3.2. Market
Forecast, 2023 - 2031
11.2.1.5.4. Middle East and Africa
11.2.1.5.4.1. Market
Estimation, 2015 - 2022
11.2.1.5.4.2. Market
Forecast, 2023 - 2031
11.2.1.5.5. Latin America
11.2.1.5.5.1. Market
Estimation, 2015 - 2022
11.2.1.5.5.2. Market
Forecast, 2023 - 2031
11.2.2. Hospital
and Clinics
11.2.2.1. Definition
11.2.2.2. Market Estimation and Penetration, 2015 - 2022
11.2.2.3. Market Forecast, 2023 - 2031
11.2.2.4. Compound Annual Growth Rate (CAGR)
11.2.2.5. Regional Bifurcation
11.2.2.5.1. North America
11.2.2.5.1.1. Market
Estimation, 2015 - 2022
11.2.2.5.1.2. Market
Forecast, 2023 - 2031
11.2.2.5.2. Europe
11.2.2.5.2.1. Market
Estimation, 2015 - 2022
11.2.2.5.2.2. Market
Forecast, 2023 - 2031
11.2.2.5.3. Asia Pacific
11.2.2.5.3.1. Market
Estimation, 2015 - 2022
11.2.2.5.3.2. Market
Forecast, 2023 - 2031
11.2.2.5.4. Middle East and Africa
11.2.2.5.4.1. Market
Estimation, 2015 - 2022
11.2.2.5.4.2. Market
Forecast, 2023 - 2031
11.2.2.5.5. Latin America
11.2.2.5.5.1. Market
Estimation, 2015 - 2022
11.2.2.5.5.2. Market
Forecast, 2023 - 2031
11.2.3. Pharmacies
11.2.3.1. Definition
11.2.3.2. Market Estimation and Penetration, 2015 - 2022
11.2.3.3. Market Forecast, 2023 - 2031
11.2.3.4. Compound Annual Growth Rate (CAGR)
11.2.3.5. Regional Bifurcation
11.2.3.5.1. North America
11.2.3.5.1.1. Market
Estimation, 2015 - 2022
11.2.3.5.1.2. Market
Forecast, 2023 - 2031
11.2.3.5.2. Europe
11.2.3.5.2.1. Market
Estimation, 2015 - 2022
11.2.3.5.2.2. Market
Forecast, 2023 - 2031
11.2.3.5.3. Asia Pacific
11.2.3.5.3.1. Market
Estimation, 2015 - 2022
11.2.3.5.3.2. Market
Forecast, 2023 - 2031
11.2.3.5.4. Middle East and Africa
11.2.3.5.4.1. Market
Estimation, 2015 - 2022
11.2.3.5.4.2. Market
Forecast, 2023 - 2031
11.2.3.5.5. Latin America
11.2.3.5.5.1. Market
Estimation, 2015 - 2022
11.2.3.5.5.2. Market
Forecast, 2023 - 2031
11.2.4. Telemedicine
and EHR companies
11.2.4.1. Definition
11.2.4.2. Market Estimation and Penetration, 2015 - 2022
11.2.4.3. Market Forecast, 2023 - 2031
11.2.4.4. Compound Annual Growth Rate (CAGR)
11.2.4.5. Regional Bifurcation
11.2.4.5.1. North America
11.2.4.5.1.1. Market
Estimation, 2015 - 2022
11.2.4.5.1.2. Market
Forecast, 2023 - 2031
11.2.4.5.2. Europe
11.2.4.5.2.1. Market
Estimation, 2015 - 2022
11.2.4.5.2.2. Market
Forecast, 2023 - 2031
11.2.4.5.3. Asia Pacific
11.2.4.5.3.1. Market
Estimation, 2015 - 2022
11.2.4.5.3.2. Market
Forecast, 2023 - 2031
11.2.4.5.4. Middle East and Africa
11.2.4.5.4.1. Market
Estimation, 2015 - 2022
11.2.4.5.4.2. Market
Forecast, 2023 - 2031
11.2.4.5.5. Latin America
11.2.4.5.5.1. Market
Estimation, 2015 - 2022
11.2.4.5.5.2. Market
Forecast, 2023 - 2031
11.2.5. Others
11.2.5.1. Definition
11.2.5.2. Market Estimation and Penetration, 2015 - 2022
11.2.5.3. Market Forecast, 2023 - 2031
11.2.5.4. Compound Annual Growth Rate (CAGR)
11.2.5.5. Regional Bifurcation
11.2.5.5.1. North America
11.2.5.5.1.1. Market
Estimation, 2015 - 2022
11.2.5.5.1.2. Market
Forecast, 2023 - 2031
11.2.5.5.2. Europe
11.2.5.5.2.1. Market
Estimation, 2015 - 2022
11.2.5.5.2.2. Market
Forecast, 2023 - 2031
11.2.5.5.3. Asia Pacific
11.2.5.5.3.1. Market
Estimation, 2015 - 2022
11.2.5.5.3.2. Market
Forecast, 2023 - 2031
11.2.5.5.4. Middle East and Africa
11.2.5.5.4.1. Market
Estimation, 2015 - 2022
11.2.5.5.4.2. Market
Forecast, 2023 - 2031
11.2.5.5.5. Latin America
11.2.5.5.5.1. Market
Estimation, 2015 - 2022
11.2.5.5.5.2. Market
Forecast, 2023 - 2031
11.3. Key
Segment for Channeling Investments
11.3.1. By End
Users
12. North America E-Priscribing Market Analysis and Forecasts, 2023
- 2031
12.1. Overview
12.1.1. North
America E-Priscribing Market Revenue (US$ Mn)
12.2. North
America E-Priscribing Market Revenue (US$ Mn) and Forecasts, By Offering
12.2.1. Solutions
12.2.1.1. Integrated
12.2.1.2. Standalone
12.2.2. Services
12.3. North
America E-Priscribing Market Revenue (US$ Mn) and Forecasts, By Deployment
12.3.1. Cloud
based
12.3.2. On
–premise
12.4. North
America E-Priscribing Market Revenue (US$ Mn) and Forecasts, By Platform
12.4.1. App
based
12.4.2. Web
based
12.5. North
America E-Priscribing Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.1. Patients
12.5.2. Hospital
and Clinics
12.5.3. Pharmacies
12.5.4. Telemedicine
and EHR companies
12.5.5. Others
12.6. North
America E-Priscribing Market Revenue (US$ Mn) and Forecasts, By Country
12.6.1. U.S
12.6.1.1. U.S E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Offering
12.6.1.1.1. Solutions
12.6.1.1.1.1. Integrated
12.6.1.1.1.2. Standalone
12.6.1.1.2. Services
12.6.1.2. U.S E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Deployment
12.6.1.2.1. Cloud based
12.6.1.2.2. On –premise
12.6.1.3. U.S E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Platform
12.6.1.3.1. App based
12.6.1.3.2. Web based
12.6.1.4. U.S E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
End Users
12.6.1.4.1. Patients
12.6.1.4.2. Hospital and Clinics
12.6.1.4.3. Pharmacies
12.6.1.4.4. Telemedicine and EHR companies
12.6.1.4.5. Others
12.6.2. Canada
12.6.2.1. Canada E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Offering
12.6.2.1.1. Solutions
12.6.2.1.1.1. Integrated
12.6.2.1.1.2. Standalone
12.6.2.1.2. Services
12.6.2.2. Canada E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Deployment
12.6.2.2.1. Cloud based
12.6.2.2.2. On –premise
12.6.2.3. Canada E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Platform
12.6.2.3.1. App based
12.6.2.3.2. Web based
12.6.2.4. Canada E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
End Users
12.6.2.4.1. Patients
12.6.2.4.2. Hospital and Clinics
12.6.2.4.3. Pharmacies
12.6.2.4.4. Telemedicine and EHR companies
12.6.2.4.5. Others
12.6.3. Mexico
12.6.3.1. Mexico E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Offering
12.6.3.1.1. Solutions
12.6.3.1.1.1. Integrated
12.6.3.1.1.2. Standalone
12.6.3.1.2. Services
12.6.3.2. Mexico E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Deployment
12.6.3.2.1. Cloud based
12.6.3.2.2. On –premise
12.6.3.3. Mexico E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Platform
12.6.3.3.1. App based
12.6.3.3.2. Web based
12.6.3.4. Mexico E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
End Users
12.6.3.4.1. Patients
12.6.3.4.2. Hospital and Clinics
12.6.3.4.3. Pharmacies
12.6.3.4.4. Telemedicine and EHR companies
12.6.3.4.5. Others
12.6.4. Rest of
North America
12.6.4.1. Rest of North America E-Priscribing Market Revenue (US$ Mn)
and Forecasts, By Offering
12.6.4.1.1. Solutions
12.6.4.1.1.1. Integrated
12.6.4.1.1.2. Standalone
12.6.4.1.2. Services
12.6.4.2. Rest of North America E-Priscribing Market Revenue (US$ Mn)
and Forecasts, By Deployment
12.6.4.2.1. Cloud based
12.6.4.2.2. On –premise
12.6.4.3. Rest of North America E-Priscribing Market Revenue (US$ Mn)
and Forecasts, By Platform
12.6.4.3.1. App based
12.6.4.3.2. Web based
12.6.4.4. Rest of North America E-Priscribing Market Revenue (US$ Mn)
and Forecasts, By End Users
12.6.4.4.1. Patients
12.6.4.4.2. Hospital and Clinics
12.6.4.4.3. Pharmacies
12.6.4.4.4. Telemedicine and EHR companies
12.6.4.4.5. Others
12.7. Key
Segment for Channeling Investments
12.7.1. By
Country
12.7.2. By
Offering
12.7.3. By
Deployment
12.7.4. By
Platform
12.7.5. By End
Users
13. Europe E-Priscribing Market Analysis and Forecasts, 2023 -
2031
13.1. Overview
13.1.1. Europe
E-Priscribing Market Revenue (US$ Mn)
13.2. Europe
E-Priscribing Market Revenue (US$ Mn) and Forecasts, By Offering
13.2.1. Solutions
13.2.1.1. Integrated
13.2.1.2. Standalone
13.2.2. Services
13.3. Europe
E-Priscribing Market Revenue (US$ Mn) and Forecasts, By Deployment
13.3.1. Cloud
based
13.3.2. On
–premise
13.4. Europe
E-Priscribing Market Revenue (US$ Mn) and Forecasts, By Platform
13.4.1. App
based
13.4.2. Web
based
13.5. Europe
E-Priscribing Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.1. Patients
13.5.2. Hospital
and Clinics
13.5.3. Pharmacies
13.5.4. Telemedicine
and EHR companies
13.5.5. Others
13.6. Europe
E-Priscribing Market Revenue (US$ Mn) and Forecasts, By Country
13.6.1. France
13.6.1.1. France E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Offering
13.6.1.1.1. Solutions
13.6.1.1.1.1. Integrated
13.6.1.1.1.2. Standalone
13.6.1.1.2. Services
13.6.1.2. France E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Deployment
13.6.1.2.1. Cloud based
13.6.1.2.2. On –premise
13.6.1.3. France E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Platform
13.6.1.3.1. App based
13.6.1.3.2. Web based
13.6.1.4. France E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
End Users
13.6.1.4.1. Patients
13.6.1.4.2. Hospital and Clinics
13.6.1.4.3. Pharmacies
13.6.1.4.4. Telemedicine and EHR companies
13.6.1.4.5. Others
13.6.2. The UK
13.6.2.1. The UK E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Offering
13.6.2.1.1. Solutions
13.6.2.1.1.1. Integrated
13.6.2.1.1.2. Standalone
13.6.2.1.2. Services
13.6.2.2. The UK E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Deployment
13.6.2.2.1. Cloud based
13.6.2.2.2. On –premise
13.6.2.3. The UK E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Platform
13.6.2.3.1. App based
13.6.2.3.2. Web based
13.6.2.4. The UK E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
End Users
13.6.2.4.1. Patients
13.6.2.4.2. Hospital and Clinics
13.6.2.4.3. Pharmacies
13.6.2.4.4. Telemedicine and EHR companies
13.6.2.4.5. Others
13.6.3. Spain
13.6.3.1. Spain E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Offering
13.6.3.1.1. Solutions
13.6.3.1.1.1. Integrated
13.6.3.1.1.2. Standalone
13.6.3.1.2. Services
13.6.3.2. Spain E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Deployment
13.6.3.2.1. Cloud based
13.6.3.2.2. On –premise
13.6.3.3. Spain E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Platform
13.6.3.3.1. App based
13.6.3.3.2. Web based
13.6.3.4. Spain E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
End Users
13.6.3.4.1. Patients
13.6.3.4.2. Hospital and Clinics
13.6.3.4.3. Pharmacies
13.6.3.4.4. Telemedicine and EHR companies
13.6.3.4.5. Others
13.6.4. Germany
13.6.4.1. Germany E-Priscribing Market Revenue (US$ Mn) and Forecasts,
By Offering
13.6.4.1.1. Solutions
13.6.4.1.1.1. Integrated
13.6.4.1.1.2. Standalone
13.6.4.1.2. Services
13.6.4.2. Germany E-Priscribing Market Revenue (US$ Mn) and Forecasts,
By Deployment
13.6.4.2.1. Cloud based
13.6.4.2.2. On –premise
13.6.4.3. Germany E-Priscribing Market Revenue (US$ Mn) and Forecasts,
By Platform
13.6.4.3.1. App based
13.6.4.3.2. Web based
13.6.4.4. Germany E-Priscribing Market Revenue (US$ Mn) and Forecasts,
By End Users
13.6.4.4.1. Patients
13.6.4.4.2. Hospital and Clinics
13.6.4.4.3. Pharmacies
13.6.4.4.4. Telemedicine and EHR companies
13.6.4.4.5. Others
13.6.5. Italy
13.6.5.1. Italy E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Offering
13.6.5.1.1. Solutions
13.6.5.1.1.1. Integrated
13.6.5.1.1.2. Standalone
13.6.5.1.2. Services
13.6.5.2. Italy E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Deployment
13.6.5.2.1. Cloud based
13.6.5.2.2. On –premise
13.6.5.3. Italy E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Platform
13.6.5.3.1. App based
13.6.5.3.2. Web based
13.6.5.4. Italy E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
End Users
13.6.5.4.1. Patients
13.6.5.4.2. Hospital and Clinics
13.6.5.4.3. Pharmacies
13.6.5.4.4. Telemedicine and EHR companies
13.6.5.4.5. Others
13.6.6. Nordic
Countries
13.6.6.1. Nordic Countries E-Priscribing Market Revenue (US$ Mn) and
Forecasts, By Offering
13.6.6.1.1. Solutions
13.6.6.1.1.1. Integrated
13.6.6.1.1.2. Standalone
13.6.6.1.2. Services
13.6.6.2. Nordic Countries E-Priscribing Market Revenue (US$ Mn) and
Forecasts, By Deployment
13.6.6.2.1. Cloud based
13.6.6.2.2. On –premise
13.6.6.3. Nordic Countries E-Priscribing Market Revenue (US$ Mn) and
Forecasts, By Platform
13.6.6.3.1. App based
13.6.6.3.2. Web based
13.6.6.4. Nordic Countries E-Priscribing Market Revenue (US$ Mn) and
Forecasts, By End Users
13.6.6.4.1. Patients
13.6.6.4.2. Hospital and Clinics
13.6.6.4.3. Pharmacies
13.6.6.4.4. Telemedicine and EHR companies
13.6.6.4.5. Others
13.6.6.5. Nordic Countries E-Priscribing Market Revenue (US$ Mn) and
Forecasts, By Country
13.6.6.5.1. Denmark
13.6.6.5.2. Finland
13.6.6.5.3. Iceland
13.6.6.5.4. Sweden
13.6.6.5.5. Norway
13.6.7. Benelux
Union
13.6.7.1. Benelux Union E-Priscribing Market Revenue (US$ Mn) and
Forecasts, By Offering
13.6.7.1.1. Solutions
13.6.7.1.1.1. Integrated
13.6.7.1.1.2. Standalone
13.6.7.1.2. Services
13.6.7.2. Benelux Union E-Priscribing Market Revenue (US$ Mn) and
Forecasts, By Deployment
13.6.7.2.1. Cloud based
13.6.7.2.2. On –premise
13.6.7.3. Benelux Union E-Priscribing Market Revenue (US$ Mn) and
Forecasts, By Platform
13.6.7.3.1. App based
13.6.7.3.2. Web based
13.6.7.4. Benelux Union E-Priscribing Market Revenue (US$ Mn) and
Forecasts, By End Users
13.6.7.4.1. Patients
13.6.7.4.2. Hospital and Clinics
13.6.7.4.3. Pharmacies
13.6.7.4.4. Telemedicine and EHR companies
13.6.7.4.5. Others
13.6.7.5. Benelux Union E-Priscribing Market Revenue (US$ Mn) and
Forecasts, By Country
13.6.7.5.1. Belgium
13.6.7.5.2. The Netherlands
13.6.7.5.3. Luxembourg
13.6.8. Rest of
Europe
13.6.8.1. Rest of Europe E-Priscribing Market Revenue (US$ Mn) and
Forecasts, By Offering
13.6.8.1.1. Solutions
13.6.8.1.1.1. Integrated
13.6.8.1.1.2. Standalone
13.6.8.1.2. Services
13.6.8.2. Rest of Europe E-Priscribing Market Revenue (US$ Mn) and
Forecasts, By Deployment
13.6.8.2.1. Cloud based
13.6.8.2.2. On –premise
13.6.8.3. Rest of Europe E-Priscribing Market Revenue (US$ Mn) and
Forecasts, By Platform
13.6.8.3.1. App based
13.6.8.3.2. Web based
13.6.8.4. Rest of Europe E-Priscribing Market Revenue (US$ Mn) and
Forecasts, By End Users
13.6.8.4.1. Patients
13.6.8.4.2. Hospital and Clinics
13.6.8.4.3. Pharmacies
13.6.8.4.4. Telemedicine and EHR companies
13.6.8.4.5. Others
13.7. Key
Segment for Channeling Investments
13.7.1. By
Country
13.7.2. By
Offering
13.7.3. By
Deployment
13.7.4. By
Platform
13.7.5. By End
Users
14. Asia Pacific E-Priscribing Market Analysis and Forecasts, 2023
- 2031
14.1. Overview
14.1.1. Asia
Pacific E-Priscribing Market Revenue (US$ Mn)
14.2. Asia
Pacific E-Priscribing Market Revenue (US$ Mn) and Forecasts, By Offering
14.2.1. Solutions
14.2.1.1. Integrated
14.2.1.2. Standalone
14.2.2. Services
14.3. Asia
Pacific E-Priscribing Market Revenue (US$ Mn) and Forecasts, By Deployment
14.3.1. Cloud
based
14.3.2. On
–premise
14.4. Asia
Pacific E-Priscribing Market Revenue (US$ Mn) and Forecasts, By Platform
14.4.1. App
based
14.4.2. Web
based
14.5. Asia
Pacific E-Priscribing Market Revenue (US$ Mn) and Forecasts, By End Users
14.5.1. Patients
14.5.2. Hospital
and Clinics
14.5.3. Pharmacies
14.5.4. Telemedicine
and EHR companies
14.5.5. Others
14.6. Asia
Pacific E-Priscribing Market Revenue (US$ Mn) and Forecasts, By Country
14.6.1. China
14.6.1.1. China E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Offering
14.6.1.1.1. Solutions
14.6.1.1.1.1. Integrated
14.6.1.1.1.2. Standalone
14.6.1.1.2. Services
14.6.1.2. China E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Deployment
14.6.1.2.1. Cloud based
14.6.1.2.2. On –premise
14.6.1.3. China E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Platform
14.6.1.3.1. App based
14.6.1.3.2. Web based
14.6.1.4. China E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
End Users
14.6.1.4.1. Patients
14.6.1.4.2. Hospital and Clinics
14.6.1.4.3. Pharmacies
14.6.1.4.4. Telemedicine and EHR companies
14.6.1.4.5. Others
14.6.2. Japan
14.6.2.1. Japan E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Offering
14.6.2.1.1. Solutions
14.6.2.1.1.1. Integrated
14.6.2.1.1.2. Standalone
14.6.2.1.2. Services
14.6.2.2. Japan E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Deployment
14.6.2.2.1. Cloud based
14.6.2.2.2. On –premise
14.6.2.3. Japan E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Platform
14.6.2.3.1. App based
14.6.2.3.2. Web based
14.6.2.4. Japan E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
End Users
14.6.2.4.1. Patients
14.6.2.4.2. Hospital and Clinics
14.6.2.4.3. Pharmacies
14.6.2.4.4. Telemedicine and EHR companies
14.6.2.4.5. Others
14.6.3. India
14.6.3.1. India E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Offering
14.6.3.1.1. Solutions
14.6.3.1.1.1. Integrated
14.6.3.1.1.2. Standalone
14.6.3.1.2. Services
14.6.3.2. India E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Deployment
14.6.3.2.1. Cloud based
14.6.3.2.2. On –premise
14.6.3.3. India E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Platform
14.6.3.3.1. App based
14.6.3.3.2. Web based
14.6.3.4. India E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
End Users
14.6.3.4.1. Patients
14.6.3.4.2. Hospital and Clinics
14.6.3.4.3. Pharmacies
14.6.3.4.4. Telemedicine and EHR companies
14.6.3.4.5. Others
14.6.4. New
Zealand
14.6.4.1. New Zealand E-Priscribing Market Revenue (US$ Mn) and
Forecasts, By Offering
14.6.4.1.1. Solutions
14.6.4.1.1.1. Integrated
14.6.4.1.1.2. Standalone
14.6.4.1.2. Services
14.6.4.2. New Zealand E-Priscribing Market Revenue (US$ Mn) and
Forecasts, By Deployment
14.6.4.2.1. Cloud based
14.6.4.2.2. On –premise
14.6.4.3. New Zealand E-Priscribing Market Revenue (US$ Mn) and
Forecasts, By Platform
14.6.4.3.1. App based
14.6.4.3.2. Web based
14.6.4.4. New Zealand E-Priscribing Market Revenue (US$ Mn) and
Forecasts, By End Users
14.6.4.4.1. Patients
14.6.4.4.2. Hospital and Clinics
14.6.4.4.3. Pharmacies
14.6.4.4.4. Telemedicine and EHR companies
14.6.4.4.5. Others
14.6.5. Australia
14.6.5.1. Australia E-Priscribing Market Revenue (US$ Mn) and Forecasts,
By Offering
14.6.5.1.1. Solutions
14.6.5.1.1.1. Integrated
14.6.5.1.1.2. Standalone
14.6.5.1.2. Services
14.6.5.2. Australia E-Priscribing Market Revenue (US$ Mn) and Forecasts,
By Deployment
14.6.5.2.1. Cloud based
14.6.5.2.2. On –premise
14.6.5.3. Australia E-Priscribing Market Revenue (US$ Mn) and Forecasts,
By Platform
14.6.5.3.1. App based
14.6.5.3.2. Web based
14.6.5.4. Australia E-Priscribing Market Revenue (US$ Mn) and Forecasts,
By End Users
14.6.5.4.1. Patients
14.6.5.4.2. Hospital and Clinics
14.6.5.4.3. Pharmacies
14.6.5.4.4. Telemedicine and EHR companies
14.6.5.4.5. Others
14.6.6. South
Korea
14.6.6.1. South Korea E-Priscribing Market Revenue (US$ Mn) and
Forecasts, By Offering
14.6.6.1.1. Solutions
14.6.6.1.1.1. Integrated
14.6.6.1.1.2. Standalone
14.6.6.1.2. Services
14.6.6.2. South Korea E-Priscribing Market Revenue (US$ Mn) and
Forecasts, By Deployment
14.6.6.2.1. Cloud based
14.6.6.2.2. On –premise
14.6.6.3. South Korea E-Priscribing Market Revenue (US$ Mn) and
Forecasts, By Platform
14.6.6.3.1. App based
14.6.6.3.2. Web based
14.6.6.4. South Korea E-Priscribing Market Revenue (US$ Mn) and
Forecasts, By End Users
14.6.6.4.1. Patients
14.6.6.4.2. Hospital and Clinics
14.6.6.4.3. Pharmacies
14.6.6.4.4. Telemedicine and EHR companies
14.6.6.4.5. Others
14.6.7. Southeast
Asia
14.6.7.1. Southeast Asia E-Priscribing Market Revenue (US$ Mn) and
Forecasts, By Offering
14.6.7.1.1. Solutions
14.6.7.1.1.1. Integrated
14.6.7.1.1.2. Standalone
14.6.7.1.2. Services
14.6.7.2. Southeast Asia E-Priscribing Market Revenue (US$ Mn) and
Forecasts, By Deployment
14.6.7.2.1. Cloud based
14.6.7.2.2. On –premise
14.6.7.3. Southeast Asia E-Priscribing Market Revenue (US$ Mn) and
Forecasts, By Platform
14.6.7.3.1. App based
14.6.7.3.2. Web based
14.6.7.4. Southeast Asia E-Priscribing Market Revenue (US$ Mn) and
Forecasts, By End Users
14.6.7.4.1. Patients
14.6.7.4.2. Hospital and Clinics
14.6.7.4.3. Pharmacies
14.6.7.4.4. Telemedicine and EHR companies
14.6.7.4.5. Others
14.6.7.5. Southeast Asia E-Priscribing Market Revenue (US$ Mn) and
Forecasts, By Country
14.6.7.5.1. Indonesia
14.6.7.5.2. Thailand
14.6.7.5.3. Malaysia
14.6.7.5.4. Singapore
14.6.7.5.5. Rest of Southeast Asia
14.6.8. Rest of
Asia Pacific
14.6.8.1. Rest of Asia Pacific E-Priscribing Market Revenue (US$ Mn) and
Forecasts, By Offering
14.6.8.1.1. Solutions
14.6.8.1.1.1. Integrated
14.6.8.1.1.2. Standalone
14.6.8.1.2. Services
14.6.8.2. Rest of Asia Pacific E-Priscribing Market Revenue (US$ Mn) and
Forecasts, By Deployment
14.6.8.2.1. Cloud based
14.6.8.2.2. On –premise
14.6.8.3. Rest of Asia Pacific E-Priscribing Market Revenue (US$ Mn) and
Forecasts, By Platform
14.6.8.3.1. App based
14.6.8.3.2. Web based
14.6.8.4. Rest of Asia Pacific E-Priscribing Market Revenue (US$ Mn) and
Forecasts, By End Users
14.6.8.4.1. Patients
14.6.8.4.2. Hospital and Clinics
14.6.8.4.3. Pharmacies
14.6.8.4.4. Telemedicine and EHR companies
14.6.8.4.5. Others
14.7. Key
Segment for Channeling Investments
14.7.1. By
Country
14.7.2. By
Offering
14.7.3. By
Deployment
14.7.4. By
Platform
14.7.5. By End
Users
15. Middle East and Africa E-Priscribing Market Analysis and
Forecasts, 2023 - 2031
15.1. Overview
15.1.1. Middle
East and Africa E-Priscribing Market Revenue (US$ Mn)
15.2. Middle
East and Africa E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Offering
15.2.1. Solutions
15.2.1.1. Integrated
15.2.1.2. Standalone
15.2.2. Services
15.3. Middle
East and Africa E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Deployment
15.3.1. Cloud
based
15.3.2. On
–premise
15.4. Middle
East and Africa E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Platform
15.4.1. App
based
15.4.2. Web
based
15.5. Middle
East and Africa E-Priscribing Market Revenue (US$ Mn) and Forecasts, By End
Users
15.5.1. Patients
15.5.2. Hospital
and Clinics
15.5.3. Pharmacies
15.5.4. Telemedicine
and EHR companies
15.5.5. Others
15.6. Middle
East and Africa E-Priscribing Market Revenue (US$ Mn) and Forecasts, By Country
15.6.1. Saudi
Arabia
15.6.1.1. Saudi Arabia E-Priscribing Market Revenue (US$ Mn) and
Forecasts, By Offering
15.6.1.1.1. Solutions
15.6.1.1.1.1. Integrated
15.6.1.1.1.2. Standalone
15.6.1.1.2. Services
15.6.1.2. Saudi Arabia E-Priscribing Market Revenue (US$ Mn) and
Forecasts, By Deployment
15.6.1.2.1. Cloud based
15.6.1.2.2. On –premise
15.6.1.3. Saudi Arabia E-Priscribing Market Revenue (US$ Mn) and
Forecasts, By Platform
15.6.1.3.1. App based
15.6.1.3.2. Web based
15.6.1.4. Saudi Arabia E-Priscribing Market Revenue (US$ Mn) and
Forecasts, By End Users
15.6.1.4.1. Patients
15.6.1.4.2. Hospital and Clinics
15.6.1.4.3. Pharmacies
15.6.1.4.4. Telemedicine and EHR companies
15.6.1.4.5. Others
15.6.2. UAE
15.6.2.1. UAE E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Offering
15.6.2.1.1. Solutions
15.6.2.1.1.1. Integrated
15.6.2.1.1.2. Standalone
15.6.2.1.2. Services
15.6.2.2. UAE E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Deployment
15.6.2.2.1. Cloud based
15.6.2.2.2. On –premise
15.6.2.3. UAE E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Platform
15.6.2.3.1. App based
15.6.2.3.2. Web based
15.6.2.4. UAE E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
End Users
15.6.2.4.1. Patients
15.6.2.4.2. Hospital and Clinics
15.6.2.4.3. Pharmacies
15.6.2.4.4. Telemedicine and EHR companies
15.6.2.4.5. Others
15.6.3. Egypt
15.6.3.1. Egypt E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Offering
15.6.3.1.1. Solutions
15.6.3.1.1.1. Integrated
15.6.3.1.1.2. Standalone
15.6.3.1.2. Services
15.6.3.2. Egypt E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Deployment
15.6.3.2.1. Cloud based
15.6.3.2.2. On –premise
15.6.3.3. Egypt E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Platform
15.6.3.3.1. App based
15.6.3.3.2. Web based
15.6.3.4. Egypt E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
End Users
15.6.3.4.1. Patients
15.6.3.4.2. Hospital and Clinics
15.6.3.4.3. Pharmacies
15.6.3.4.4. Telemedicine and EHR companies
15.6.3.4.5. Others
15.6.4. Kuwait
15.6.4.1. Kuwait E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Offering
15.6.4.1.1. Solutions
15.6.4.1.1.1. Integrated
15.6.4.1.1.2. Standalone
15.6.4.1.2. Services
15.6.4.2. Kuwait E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Deployment
15.6.4.2.1. Cloud based
15.6.4.2.2. On –premise
15.6.4.3. Kuwait E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Platform
15.6.4.3.1. App based
15.6.4.3.2. Web based
15.6.4.4. Kuwait E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
End Users
15.6.4.4.1. Patients
15.6.4.4.2. Hospital and Clinics
15.6.4.4.3. Pharmacies
15.6.4.4.4. Telemedicine and EHR companies
15.6.4.4.5. Others
15.6.5. South
Africa
15.6.5.1. South Africa E-Priscribing Market Revenue (US$ Mn) and
Forecasts, By Offering
15.6.5.1.1. Solutions
15.6.5.1.1.1. Integrated
15.6.5.1.1.2. Standalone
15.6.5.1.2. Services
15.6.5.2. South Africa E-Priscribing Market Revenue (US$ Mn) and
Forecasts, By Deployment
15.6.5.2.1. Cloud based
15.6.5.2.2. On –premise
15.6.5.3. South Africa E-Priscribing Market Revenue (US$ Mn) and
Forecasts, By Platform
15.6.5.3.1. App based
15.6.5.3.2. Web based
15.6.5.4. South Africa E-Priscribing Market Revenue (US$ Mn) and
Forecasts, By End Users
15.6.5.4.1. Patients
15.6.5.4.2. Hospital and Clinics
15.6.5.4.3. Pharmacies
15.6.5.4.4. Telemedicine and EHR companies
15.6.5.4.5. Others
15.6.6. Rest of
Middle East & Africa
15.6.6.1. Rest of Middle East & Africa E-Priscribing Market Revenue
(US$ Mn) and Forecasts, By Offering
15.6.6.1.1. Solutions
15.6.6.1.1.1. Integrated
15.6.6.1.1.2. Standalone
15.6.6.1.2. Services
15.6.6.2. Rest of Middle East & Africa E-Priscribing Market Revenue
(US$ Mn) and Forecasts, By Deployment
15.6.6.2.1. Cloud based
15.6.6.2.2. On –premise
15.6.6.3. Rest of Middle East & Africa E-Priscribing Market Revenue
(US$ Mn) and Forecasts, By Platform
15.6.6.3.1. App based
15.6.6.3.2. Web based
15.6.6.4. Rest of Middle East & Africa E-Priscribing Market Revenue
(US$ Mn) and Forecasts, By End Users
15.6.6.4.1. Patients
15.6.6.4.2. Hospital and Clinics
15.6.6.4.3. Pharmacies
15.6.6.4.4. Telemedicine and EHR companies
15.6.6.4.5. Others
15.7. Key
Segment for Channeling Investments
15.7.1. By
Country
15.7.2. By
Offering
15.7.3. By
Deployment
15.7.4. By
Platform
15.7.5. By End
Users
16. Latin America E-Priscribing Market Analysis and Forecasts, 2023
- 2031
16.1. Overview
16.1.1. Latin
America E-Priscribing Market Revenue (US$ Mn)
16.2. Latin
America E-Priscribing Market Revenue (US$ Mn) and Forecasts, By Offering
16.2.1. Solutions
16.2.1.1. Integrated
16.2.1.2. Standalone
16.2.2. Services
16.3. Latin
America E-Priscribing Market Revenue (US$ Mn) and Forecasts, By Deployment
16.3.1. Cloud
based
16.3.2. On
–premise
16.4. Latin
America E-Priscribing Market Revenue (US$ Mn) and Forecasts, By Platform
16.4.1. App
based
16.4.2. Web
based
16.5. Latin
America E-Priscribing Market Revenue (US$ Mn) and Forecasts, By End Users
16.5.1. Patients
16.5.2. Hospital
and Clinics
16.5.3. Pharmacies
16.5.4. Telemedicine
and EHR companies
16.5.5. Others
16.6. Latin
America E-Priscribing Market Revenue (US$ Mn) and Forecasts, By Country
16.6.1. Brazil
16.6.1.1. Brazil E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Offering
16.6.1.1.1. Solutions
16.6.1.1.1.1. Integrated
16.6.1.1.1.2. Standalone
16.6.1.1.2. Services
16.6.1.2. Brazil E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Deployment
16.6.1.2.1. Cloud based
16.6.1.2.2. On –premise
16.6.1.3. Brazil E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
Platform
16.6.1.3.1. App based
16.6.1.3.2. Web based
16.6.1.4. Brazil E-Priscribing Market Revenue (US$ Mn) and Forecasts, By
End Users
16.6.1.4.1. Patients
16.6.1.4.2. Hospital and Clinics
16.6.1.4.3. Pharmacies
16.6.1.4.4. Telemedicine and EHR companies
16.6.1.4.5. Others
16.6.2. Argentina
16.6.2.1. Argentina E-Priscribing Market Revenue (US$ Mn) and Forecasts,
By Offering
16.6.2.1.1. Solutions
16.6.2.1.1.1. Integrated
16.6.2.1.1.2. Standalone
16.6.2.1.2. Services
16.6.2.2. Argentina E-Priscribing Market Revenue (US$ Mn) and Forecasts,
By Deployment
16.6.2.2.1. Cloud based
16.6.2.2.2. On –premise
16.6.2.3. Argentina E-Priscribing Market Revenue (US$ Mn) and Forecasts,
By Platform
16.6.2.3.1. App based
16.6.2.3.2. Web based
16.6.2.4. Argentina E-Priscribing Market Revenue (US$ Mn) and Forecasts,
By End Users
16.6.2.4.1. Patients
16.6.2.4.2. Hospital and Clinics
16.6.2.4.3. Pharmacies
16.6.2.4.4. Telemedicine and EHR companies
16.6.2.4.5. Others
16.6.3. Rest of
Latin America
16.6.3.1. Rest of Latin America E-Priscribing Market Revenue (US$ Mn)
and Forecasts, By Offering
16.6.3.1.1. Solutions
16.6.3.1.1.1. Integrated
16.6.3.1.1.2. Standalone
16.6.3.1.2. Services
16.6.3.2. Rest of Latin America E-Priscribing Market Revenue (US$ Mn)
and Forecasts, By Deployment
16.6.3.2.1. Cloud based
16.6.3.2.2. On –premise
16.6.3.3. Rest of Latin America E-Priscribing Market Revenue (US$ Mn)
and Forecasts, By Platform
16.6.3.3.1. App based
16.6.3.3.2. Web based
16.6.3.4. Rest of Latin America E-Priscribing Market Revenue (US$ Mn)
and Forecasts, By End Users
16.6.3.4.1. Patients
16.6.3.4.2. Hospital and Clinics
16.6.3.4.3. Pharmacies
16.6.3.4.4. Telemedicine and EHR companies
16.6.3.4.5. Others
16.7. Key
Segment for Channeling Investments
16.7.1. By
Country
16.7.2. By
Offering
16.7.3. By
Deployment
16.7.4. By
Platform
16.7.5. By End
Users
17. Competitive Benchmarking
17.1. Brand
Benchmarking
17.2. Market
Share Analysis, 2022
17.3. Global
Presence and Growth Strategies
17.3.1. Mergers
and Acquisitions
17.3.2. Product
Launches
17.3.3. Investments
Trends
17.3.4. R&D
Initiatives
18. Player Profiles
18.1. Advanced
Data Systems.
18.1.1. Company
Details
18.1.2. Company
Overview
18.1.3. Product
Offerings
18.1.4. Key
Developments
18.1.5. Financial
Analysis
18.1.6. SWOT
Analysis
18.1.7. Business
Strategies
18.2. AdvancedMD,
Inc.
18.2.1. Company
Details
18.2.2. Company
Overview
18.2.3. Product
Offerings
18.2.4. Key
Developments
18.2.5. Financial
Analysis
18.2.6. SWOT
Analysis
18.2.7. Business
Strategies
18.3. Bizmatics,
Inc.
18.3.1. Company
Details
18.3.2. Company
Overview
18.3.3. Product
Offerings
18.3.4. Key
Developments
18.3.5. Financial
Analysis
18.3.6. SWOT
Analysis
18.3.7. Business
Strategies
18.4. DrFirst
18.4.1. Company
Details
18.4.2. Company
Overview
18.4.3. Product
Offerings
18.4.4. Key
Developments
18.4.5. Financial
Analysis
18.4.6. SWOT
Analysis
18.4.7. Business
Strategies
18.5. eazyScripts
18.5.1. Company
Details
18.5.2. Company
Overview
18.5.3. Product
Offerings
18.5.4. Key
Developments
18.5.5. Financial
Analysis
18.5.6. SWOT
Analysis
18.5.7. Business
Strategies
18.6. Henry
Schein Medical Systems, Inc
18.6.1. Company
Details
18.6.2. Company
Overview
18.6.3. Product
Offerings
18.6.4. Key
Developments
18.6.5. Financial
Analysis
18.6.6. SWOT
Analysis
18.6.7. Business
Strategies
18.7. Innovation
Compounding
18.7.1. Company
Details
18.7.2. Company
Overview
18.7.3. Product
Offerings
18.7.4. Key
Developments
18.7.5. Financial
Analysis
18.7.6. SWOT
Analysis
18.7.7. Business
Strategies
18.8. Kareo,
Inc.
18.8.1. Company
Details
18.8.2. Company
Overview
18.8.3. Product
Offerings
18.8.4. Key
Developments
18.8.5. Financial
Analysis
18.8.6. SWOT
Analysis
18.8.7. Business
Strategies
18.9. MDToolbox
18.9.1. Company
Details
18.9.2. Company
Overview
18.9.3. Product
Offerings
18.9.4. Key
Developments
18.9.5. Financial
Analysis
18.9.6. SWOT
Analysis
18.9.7. Business
Strategies
18.10. MedicalMine
Inc.
18.10.1. Company
Details
18.10.2. Company
Overview
18.10.3. Product
Offerings
18.10.4. Key
Developments
18.10.5. Financial
Analysis
18.10.6. SWOT
Analysis
18.10.7. Business
Strategies
18.11. Practice
Fusion, Inc.
18.11.1. Company
Details
18.11.2. Company
Overview
18.11.3. Product
Offerings
18.11.4. Key
Developments
18.11.5. Financial
Analysis
18.11.6. SWOT
Analysis
18.11.7. Business
Strategies
18.12. PRN
Software, LLC.
18.12.1. Company
Details
18.12.2. Company
Overview
18.12.3. Product
Offerings
18.12.4. Key
Developments
18.12.5. Financial
Analysis
18.12.6. SWOT
Analysis
18.12.7. Business
Strategies
18.13. RXNT
18.13.1. Company
Details
18.13.2. Company
Overview
18.13.3. Product
Offerings
18.13.4. Key
Developments
18.13.5. Financial
Analysis
18.13.6. SWOT
Analysis
18.13.7. Business
Strategies
18.14. Streamline
Healthcare Solutions
18.14.1. Company
Details
18.14.2. Company
Overview
18.14.3. Product
Offerings
18.14.4. Key
Developments
18.14.5. Financial
Analysis
18.14.6. SWOT
Analysis
18.14.7. Business
Strategies
18.15. Surescripts
18.15.1. Company
Details
18.15.2. Company
Overview
18.15.3. Product
Offerings
18.15.4. Key
Developments
18.15.5. Financial
Analysis
18.15.6. SWOT
Analysis
18.15.7. Business
Strategies
18.16. Veradigm
LLC
18.16.1. Company
Details
18.16.2. Company
Overview
18.16.3. Product
Offerings
18.16.4. Key
Developments
18.16.5. Financial
Analysis
18.16.6. SWOT
Analysis
18.16.7. Business
Strategies
18.17. Wolters
Kluwer N.V.
18.17.1. Company
Details
18.17.2. Company
Overview
18.17.3. Product
Offerings
18.17.4. Key
Developments
18.17.5. Financial
Analysis
18.17.6. SWOT
Analysis
18.17.7. Business Strategies
18.18. Other
Market Participants
19. Key Findings
Note: This ToC is tentative and can be changed
according to the research study conducted during the course of
report completion.
**Exclusive for Multi-User and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.